4th International Caparica Conference on Leishmaniasis 2025

12th – 16th October 2025 | Caparica | Portugal

Scientific Committee

Carlos Lodeiro Espiño, PhD

LAQV-REQUIMTE, FCT- University NOVA of Lisbon (Lisbon, Portugal)

 

José Luís Capelo Martínez, PhD

LAQV-REQUIMTE, FCT- University NOVA of Lisbon (Lisbon, Portugal)

 

Hugo Miguel Santos, PhD

LAQV-REQUIMTE, FCT- University NOVA of Lisbon (Lisbon, Portugal)

 

Elisabete Oliveira, PhD

LAQV-REQUIMTE, FCT- University NOVA of Lisbon (Lisbon, Portugal)

Javier Fernández Lodeiro, PhD

LAQV-REQUIMTE, FCT- University NOVA of Lisbon (Lisbon, Portugal)

 

Gilberto Igrejas, PhD

University of Trás-os-Montes and Alto Douro, ECVA-DGB | LAQV-REQUIMTE (Portugal)

 

Hira Nakhasi, PhD

U.S. Food and Drug Administration (USA)

Laia Solano-Gallego, PhD

Universitat Autònoma de Barcelona (Spain)

Christian Bogdan, PhD

University Hospital of Erlangen and Friedrich-Alexander-University (FAU) (Germany)

Jeronimo Carnes, PhD

Leti Pharma (Spain)

Hiro Goto, PhD

Department of Preventive Medicine, and Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo (Brazil)

Pleiotropic effects of insulin-like growth factor-I on Leishmania and leishmaniasis reveal species-related differences in immunometabolism

Lars Gille, PhD

University of Veterinary Medicine, Vienna (Austria)

Sergi Segarra, PhD

Bioiberica (Spain)

Ingo Schäfer, PhD

Laboklin GmbH & Co. KG, Department of Clinical Pathology, Bad Kissingen, Bavaria (Germany)

Albert Descoteaux, PhD

INRS (Canada)

Dan Zilberstein, PhD

Technion – Israel Institute of Technology (Israel)

Márcia Dalastra Laurenti, PhD

Medical School, University of São Paulo, São Paulo (Brazil)

Non-Ulcerated Cutaneous Leishmaniasis, a Benign Clinical Form of Leishmania (L.) infantum chagasi Infection